Skip to content

Transparency of clinical trials data

Related people
Rudoni Alexandre
Alexandre Rudoni

Partner

Paris

View profile →

Benard Laetitia
Laëtitia Bénard

Partner

Paris

View profile →

28 May 2013

This alert contains an overview of current rules on access to clinical trials data, an overview of the anticipated legislative changes and provides a summary of the issues that the new regulation may bring, including concerns raised by the industry. This is an area of considerable interest to the industry at large and to many of our clients, and is one which Allen & Overy is following in detail.